Harnessing Deep Learning to Revolutionize Precision Cancer Therapy
3 Articles
3 Articles
A team led by Altuna Akalin from the Max Delbrück Center has developed a new tool that guides cancer patients and their doctors toward the best treatment. Their latest tool uses deep neural networks and can evaluate multimodal data. Every year, nearly fifty new cancers are diagnosed...
Deep Learning Integrates Multi-Omics for Precision Oncology Decision Making
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology platform at the Berlin Institute for Medical Systems Biology of the Max Delbrück Center (MDC-BIMSB) says, “it is becoming increasingly difficult to keep track and to select the treatment methods from which the people affected—each with their very individ…
Harnessing Deep Learning to Revolutionize Precision Cancer Therapy
In a groundbreaking advance that promises to transform the landscape of precision oncology, Altuna Akalin and his research team at the Max Delbrück Center for Molecular Medicine have unveiled Flexynesis, an innovative deep learning toolkit designed to integrate and analyze complex multi-omics data alongside diverse clinical information. Published in the prestigious journal Nature Communications, this […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
